These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 620907)

  • 1. Copper toxicity in primary biliary cirrhosis.
    Scott LD
    Gastroenterology; 1978 Feb; 74(2 Pt 1):333-4. PubMed ID: 620907
    [No Abstract]   [Full Text] [Related]  

  • 2. Copper metabolism in primary biliary cirrhosis.
    Vierling JM
    Semin Liver Dis; 1981 Nov; 1(4):293-308. PubMed ID: 7051310
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of D-penicillamine on copper retention in patients with primary billiary cirrhosis.
    Deering TB; Dickson ER; Fleming CR; Geall MG; McCall JT; Baggenstoss AH
    Gastroenterology; 1977 Jun; 72(6):1208-12. PubMed ID: 870369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic copper accumulation in primary biliary cirrhosis.
    Benson GD
    Yale J Biol Med; 1979; 52(1):83-8. PubMed ID: 452626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic copper in primary biliary cirrhosis: biliary excretion and response to penicillamine treatment.
    Salaspuro MP; Pikkarainen P; Sipponen P; Vuori E; Miettinen TA
    Gut; 1981 Nov; 22(11):901-6. PubMed ID: 7308845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of immune complexes and immunoglobulins induced by D-penicillamine in primary biliary cirrhosis.
    Epstein O; De Villiers D; Jain S; Potter BJ; Thomas HC; Sherlock S
    N Engl J Med; 1979 Feb; 300(6):274-8. PubMed ID: 759879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper stains and the syndrome of primary biliary cirrhosis. Evaluation of staining methods and their usefulness for diagnosis and trials of penicillamine treatment.
    Ludwig J; McDonald GS; Dickson ER; Elveback LR; McCall JT
    Arch Pathol Lab Med; 1979 Aug; 103(9):467-70. PubMed ID: 88927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of 64Copper in primary biliary cirrhosis.
    Janssens AR; Van den Hamer CJ
    Hepatology; 1982; 2(6):822-7. PubMed ID: 7141395
    [No Abstract]   [Full Text] [Related]  

  • 9. Asymptomatic primary biliary cirrhosis. Presentation, histology, and results with D-penicillamine.
    Fleming CR; Ludwig J; Dickson ER
    Mayo Clin Proc; 1978 Sep; 53(9):587-93. PubMed ID: 355732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protein-copper complex in primary biliary cirrhosis and other chronic diffuse diseases of the liver].
    Loginov AS; Aruin LI; Shepeleva SD
    Arkh Patol; 1980; 42(4):50-5. PubMed ID: 7396755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current insights in the treatment of primary biliary cirrhosis].
    van Berge Henegouwen GP; Brandt KH; Schalm SW
    Ned Tijdschr Geneeskd; 1978 Apr; 122(16):548-50. PubMed ID: 643111
    [No Abstract]   [Full Text] [Related]  

  • 12. The copper-controlled diet: current aspects of dietary copper restriction in management of copper metabolism disorders.
    Smithgall JM
    J Am Diet Assoc; 1985 May; 85(5):609-10. PubMed ID: 3886765
    [No Abstract]   [Full Text] [Related]  

  • 13. Triethylene tetramine dihydrochloride toxicity in primary biliary cirrhosis.
    Epstein O; Sherlock S
    Gastroenterology; 1980 Jun; 78(6):1442-5. PubMed ID: 6445305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of D-penicillamine therapy in primary biliary cirrhosis.
    Jain S; Scheuer PJ; Samourian S; McGee JO
    Lancet; 1977 Apr; 1(8016):831-4. PubMed ID: 67338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary biliary cirrhosis: a challenging disease for hepatologists and immunologists.
    Jones EA
    Semin Liver Dis; 1981 Nov; 1(4):267-72. PubMed ID: 7051307
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment and prognosis of primary biliary cirrhosis.
    Sherlock S
    Semin Liver Dis; 1981 Nov; 1(4):354-64. PubMed ID: 7051314
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatic organelle pathology in primary biliary cirrhosis and the response to low-dose D-penicillamine therapy.
    Scott J; Jenkins W; Smith GP; Peters TJ
    Clin Sci (Lond); 1981 Feb; 60(2):207-12. PubMed ID: 7237933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic copper accumulation in patients with primary biliary cirrhosis.
    Takeshima H; Yagi A; Yano M; Sakamoto N; Kato S; Kuriki J; Arao M; Takikawa T; Hayashi H
    Nagoya J Med Sci; 1993 Mar; 55(1-4):115-23. PubMed ID: 8247100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The syndrome of primary biliary cirrhosis.
    Dickson ER
    J Rheumatol Suppl; 1981; 7():121-3. PubMed ID: 6939874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective clinical trial of D-penicillamine in the treatment of primary biliary cirrhosis.
    Bodenheimer HC; Schaffner F; Sternlieb I; Klion FM; Vernace S; Pezzullo J
    Hepatology; 1985; 5(6):1139-42. PubMed ID: 3905561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.